Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 66
Filter
Add more filters











Publication year range
1.
Integr Pharm Res Pract ; 12: 87-99, 2023.
Article in English | MEDLINE | ID: mdl-37124706

ABSTRACT

Purpose: Contributing to public health by supporting people's health is the social mission of community pharmacists. This multicenter, prospective case series study aimed to evaluate changes in people's behavior and health states through community pharmacists' self-care support for healthy lifestyles. Methods: The participants were recruited from voluntary adults aged ≥20 years who agreed to participate in the study, at community pharmacies in Gifu, Japan, between June and September 2021. Participants self-managed their lifestyles for six months while recording their health data, including blood pressure (BP), daily using devices (home BP monitor, body composition monitor, and activity meter) and a diet-recording app. They received lifestyle modification support at pharmacies at least once per month. Participants' subjective health status, attitudes, and behavioral changes were evaluated using self-report questionnaires. Due to the exploratory nature of this study, data were primarily analyzed descriptively. Results: Fifty-four participants aged 20 to 77 (mean age: 49.6 years; female participant proportion: 55.6%) participated in this study. Their mean weekly BP shifted almost horizontally from baseline to week 24 (systolic BP: 118.8 to 121.5 mmHg; diastolic BP: 76.1 to 77.5 mmHg). At six months, 38.9% and 35.2% of the participants reported better overall health and mental health, respectively, than at baseline. Over 85% of the participants became more proactive in improving their lifestyles regarding salt intake, diet, weight loss, and exercise, although drinking and smoking habits were more challenging to change. All the participants reported that they intended to continue to improve their lifestyle. Conclusion: The participants' responses suggested that community pharmacists' support helped increase participants' health awareness and promote their health-enhancing behaviors. However, its impact on health parameters should be further examined in future studies. More vigorous, tailored self-care support may be worth considering in developing a more effective, community-fitted health/well-being support system in Japan.

2.
J Hazard Mater ; 445: 130461, 2023 03 05.
Article in English | MEDLINE | ID: mdl-36436451

ABSTRACT

Low doses of bisphenol A (BPA), a typical endocrine-disrupting chemical (EDC), have been reported to exhibit estrogenic action in animals; however, the effects have not been fully clarified because of their non-reproducibility. Here, we developed a novel, short-term screening test for estrogen-like chemicals using in vivo bioluminescence imaging of estrogen-responsive reporter (E-Rep) mice. Comparative studies using 17α-ethinylestradiol and selective estrogen receptor modulators demonstrated that the method provides higher detection sensitivity and requires less time than the uterotrophic bioassay, a well-established, in vivo screening method for estrogen-like chemicals. Our method could detect the estrogenic effects of BPA at doses below tolerable daily intakes, whereas the uterotrophic bioassay could not. Our results indicated that in vivo bioluminescence imaging using E-Rep mice was extremely useful for screening estrogenic chemicals and detecting estrogenic effects at low doses of EDCs, including BPA. Our method should help resolve the controversy about low-dose effects of EDCs.


Subject(s)
Endocrine Disruptors , Estrogens , Mice , Animals , Estrogens/toxicity , Phenols/toxicity , Benzhydryl Compounds/toxicity , Estrone , Endocrine Disruptors/toxicity
3.
Biochem Pharmacol ; 206: 115332, 2022 12.
Article in English | MEDLINE | ID: mdl-36323391

ABSTRACT

Current in vivo developmental neurotoxicity (DNT) tests are not performed routinely for chemical risk assessment because they are time and resource intensive and require many animals. Therefore, new methodologies are required that can detect and evaluate the DNT potential of chemicals in a more simple, quantitative, and objective manner. Toward this end, we generated transgenic mice expressing reporter genes (luciferase and lacZ) under the control of the rat synapsin 1 promoter (Syn-Rep mice) and evaluated their usefulness as a DNT detection tool. Brain luciferase expression levels in Syn-Rep mice increased dramatically from just before to after birth, peaked early in the postnatal period, subsequently decreased sharply, and then remained low after weaning. This pattern is analogous to the generally recognized temporal changes in synapse numbers in the developing mammal brain. To evaluate further the responsiveness of Syn-Rep mice during DNT induction, we administered valproic acid (VPA), a reference DNT-inducing chemical, to pregnant mice and evaluated its effect on reporter gene expression in the developing brains of Syn-Rep pups. In vivo luminescence in the brains of VPA-exposed pups was significantly lower than in controls from postnatal days 4 to 13. Moreover, luciferase activity in the prefrontal cortexes of 8-week-old VPA-exposed offspring was significantly lower than in controls, reflecting the reduced number of neurons in the prefrontal cortex. These results suggest that the Syn-Rep mice are potentially useful tools for streamlined detection of chemical-induced DNT in the developing mammalian brain.


Subject(s)
Neurotoxicity Syndromes , Animals , Female , Mice , Pregnancy , Rats , Cell Line , Mammals , Neurons , Neurotoxicity Syndromes/genetics , Neurotoxicity Syndromes/metabolism , Valproic Acid/pharmacology
4.
Biol Pharm Bull ; 45(10): 1510-1517, 2022 Oct 01.
Article in English | MEDLINE | ID: mdl-35922913

ABSTRACT

Royal jelly (RJ) has beneficial effects on human health, and some of these effects are reported to be the result of its estrogenic activity; however, chemicals with estrogenic activities may disrupt physiological estrogen signaling leading to adverse effects on human health. Thus, clarification of the mode of action of RJ is needed. Here, we investigated whether the estrogen-like actions of RJ are induced via estrogen receptors (ERs)-mediated genomic actions by using an in vitro reporter assay in human choriocarcinoma JEG3 cells and an estrogen-responsive reporter (E-Rep) mouse line that can be used to sensitively detect transactivation of ERs in multiple organs simultaneously. In the in vitro reporter assay, ERs-dependent transcriptional activity was significantly increased by 17ß-estradiol (E2) treatment at concentrations of 1 nM and above, confirming that the assay was highly responsive to estrogen; however, RJ did not exhibit any agonist activity via either the α or ß form of ER. Similarly, in E-Rep mice, E2 showed significant ERs-dependent genomic action in 17 tissue types including uterus and mammary gland, whereas RJ did not. Thus, unlike endocrine-disrupting chemicals, the estrogen-like activity of RJ is unlikely to be due to genomic actions via ERs.


Subject(s)
Estrogens , Receptors, Estrogen , Action Potentials , Animals , Cell Line, Tumor , Estradiol/metabolism , Estrogen Receptor alpha , Estrogens/pharmacology , Fatty Acids , Female , Genomics , Humans , Mice , Receptors, Estrogen/genetics , Receptors, Estrogen/metabolism , Signal Transduction
5.
Int J Mol Sci ; 22(24)2021 Dec 17.
Article in English | MEDLINE | ID: mdl-34948335

ABSTRACT

Propolis is a resinous mixture produced by bees from their secretions and plant material, so its composition varies depending on its botanical origin. Propolis has several beneficial bioactivities, but its skin sensitization properties have long been suspected. Nevertheless, the skin sensitization potency of Brazilian green propolis (BGP) has not been scientifically evaluated. Here, we used scientifically reliable tests to evaluate it. In vitro antigenicity test based on the human cell line activation test (OECD TG 442E) was performed by measuring the expression of CD54 and CD86, which are indicators of the antigenicity of test substances, on THP-1 and DC2.4 cells. BGP did not affect the expression of either marker on THP-1 cells, but upregulated the expression of CD86 on DC2.4 cells, suggesting that BGP may be a skin sensitizer. Then, we performed local lymph node assay (LLNA, OECD TG 429) as a definitive in vivo test. LLNA showed that 1.70% BGP primed skin sensitization and is a "moderate sensitizer". Our results indicate scientific proof of the validity of arbitrary concentrations (1-2%), which have been used empirically, and provide the first scientific information on the safe use of BGP.


Subject(s)
Allergens , Dermatitis, Allergic Contact , Propolis/pharmacology , Skin/drug effects , Animals , Brazil , Cell Line , Female , Humans , Local Lymph Node Assay , Mice , THP-1 Cells
6.
J Toxicol Sci ; 46(8): 379-389, 2021.
Article in English | MEDLINE | ID: mdl-34334559

ABSTRACT

Activated charcoal (AC) is a potential candidate antidote against dioxins. However, it is difficult to take AC as a supplement on a daily basis, because its long-term ingestion causes side effects such as constipation and deficiency of fat-soluble essential nutrients and hypocholesterolemia. Alginate-coated AC, termed Health Carbon (HC), was developed to decrease the side effects of AC, but its pharmacological effects, including side effects, remains unclear. Here, we show that HC enhanced fecal excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and decreased some side effects of unmodified AC, such as hypocholesterolemia, in male mice. Basal diet mixed with HC or unmodified AC at various concentrations was fed to mice for 16 days following a single intraperitoneal administration of [3H]TCDD. Both HC and unmodified AC at 3% or more significantly increased fecal excretion of [3H]TCDD in comparison with the control basal diet. Consistent with this, [3H]TCDD radioactivity in the liver-a major TCDD storage organ-was markedly decreased by HC at concentrations of 3% and 10%. In an examination of potential side effects, unmodified AC at 10% or more caused significant body weight reduction and at 20% caused significant hypocholesterolemia. In contrast, HC caused weight gain reduction only at a concentration of 20%, and there was no evidence of hypocholesterolemia at any dietary HC concentration. HC not only retains the ability of AC to enhance fecal excretion of TCDD but also reduces some of the side effects of AC.


Subject(s)
Alginates , Antidotes/adverse effects , Antidotes/pharmacology , Charcoal/adverse effects , Charcoal/pharmacology , Feces , Polychlorinated Dibenzodioxins/metabolism , Administration, Oral , Alginates/administration & dosage , Animals , Antidotes/administration & dosage , Charcoal/administration & dosage , Cholesterol/blood , Constipation/chemically induced , Male , Mice, Inbred Strains , Weight Loss
7.
J Toxicol Sci ; 45(9): 581-587, 2020.
Article in English | MEDLINE | ID: mdl-32879257

ABSTRACT

Complement component 8 γ (C8γ) is a subunit of complement protein 8 (C8), which itself is a subunit of the complement cytolytic membrane attack complex. However, C8γ is also suggested to be a carrier protein for the general clearance of endogenous and exogenous compounds because it belongs to the lipocalin family of small secreted proteins that have the common ability to bind small hydrophobic ligands. Although retinoic acid, a metabolite of vitamin A, has been suggested as a potential ligand of C8γ, it remains unclear which other substances are able to bind to C8γ as ligands. Here, we evaluated the binding affinity of several organotin compounds that are ligands of a receptor of retinoic acid, retinoid X receptor, by using radioligand binding assays. The amount of [14C]triphenyltin (TPT), a tri-substituted organotin, that bound to purified recombinant C8γ was increased with increasing protein concentration, whereas that of [3H]all-trans retinoic acid and [3H]9-cis retinoic acid was unchanged. Scatchard analysis revealed that [14C]TPT bound to C8γ with an equilibrium dissociation constant (Kd) of 56.2 ± 16.2 nM. Non-radiolabeled tributyltin (TBT), another tri-substituted organotin, blocked the binding of [14C]TPT to C8γ in a competitive manner, but non-radiolabeled mono- or di-substituted organotin compounds did not. Together, our present observations indicate that TBT and TPT, but not retinoic acid or mono- or di-substituted organotin compounds, are potent ligands of C8γ, suggesting that C8γ may be involved in the toxicities of these organotin compounds.


Subject(s)
Carrier Proteins , Complement C8 , Ligands , Organotin Compounds/toxicity , Trialkyltin Compounds/toxicity , Binding, Competitive , Complement Membrane Attack Complex/chemistry , Protein Binding , Retinoid X Receptors/metabolism , Tretinoin
8.
Toxicol Lett ; 332: 130-139, 2020 Oct 10.
Article in English | MEDLINE | ID: mdl-32645461

ABSTRACT

Cadmium (Cd) is an environmental contaminant that triggers toxic effects in various tissues such as the kidney, liver, and lung. Cd can also cause abnormal iron metabolism, leading to anemia. Iron homeostasis is regulated by intestinal absorption. However, whether Cd affects the iron absorption pathway is unclear. We aimed to elucidate the relationship between the intestinal iron transporter system and Cd-induced iron deficiency anemia. C57BL/6J female and male mice, 129/Sv female mice, and DBA/2 female mice were given a single oral dose of CdCl2 by gavage. After 3 or 24 h, Cd decreased serum iron concentrations and inhibited the expression of iron transport-related genes in the duodenum. In particular, Cd decreased the levels of divalent metal transporter 1 and ferroportin 1 in the duodenum. In addition, human colon carcinoma Caco-2 cells were treated with CdCl2. After 72 h, Cd decreased the expression of iron transport-related factors in Caco-2 cells with a pattern similar to that seen in the murine duodenum. These findings suggest that Cd inhibits iron absorption through direct suppression of iron transport in duodenal enterocytes and contributes to abnormal iron metabolism.


Subject(s)
Anemia, Iron-Deficiency/chemically induced , Cadmium/toxicity , Duodenum/drug effects , Duodenum/metabolism , Iron/metabolism , Animals , Biological Transport, Active/drug effects , Caco-2 Cells , Cadmium/pharmacokinetics , Cadmium Chloride/toxicity , Cation Transport Proteins/metabolism , Female , Humans , Liver/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Inbred DBA
9.
J Hazard Mater ; 385: 121526, 2020 03 05.
Article in English | MEDLINE | ID: mdl-31732351

ABSTRACT

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), commonly referred to simply as "dioxin", is a persistent environmental pollutant. Because of its high environmental persistence and biological accumulation, humans and animals are often exposed to TCDD. Therefore, the harmful effects on humans and animals is a major concern. Although studies have elucidated the adverse estrogenic and anti-estrogenic effects of TCDD, it is unclear in which tissues TCDD exerts these effects in vivo. To investigate the estrogen-related effects of TCDD in various tissues, we generated an improved estrogen-responsive reporter transgenic mouse in which the luciferase gene luc2 is expressed in response to estrogenic signals. Using these mice, we clarified that TCDD inhibits estrogenic signaling in liver and kidney but enhances estrogenic signaling in the pituitary gland in the same individual. Expression of aryl hydrocarbon receptor, aryl hydrocarbon receptor nuclear translocator, and estrogen receptor alpha mRNA was detected in liver, kidney, and pituitary gland, suggesting that the effects of TCDD on estrogenic signaling in these organs is independent of the expression pattern of these receptors. Thus, our results indicate that TCDD exerts both estrogenic and anti-estrogenic tissue-specific effects within the same individual.


Subject(s)
Environmental Pollutants/toxicity , Estrogen Receptor Modulators/toxicity , Estrogens/toxicity , Polychlorinated Dibenzodioxins/toxicity , Animals , Cell Line, Tumor , Environmental Pollutants/pharmacokinetics , Estrogen Receptor Modulators/pharmacokinetics , Estrogens/pharmacokinetics , Female , Gene Expression/drug effects , Humans , Luciferases/genetics , Mice, Transgenic , Polychlorinated Dibenzodioxins/pharmacokinetics , Signal Transduction/drug effects , Tissue Distribution
10.
Biol Pharm Bull ; 41(2): 266-271, 2018.
Article in English | MEDLINE | ID: mdl-29386486

ABSTRACT

Corn oil, sesame oil, and 10% ethanol in corn oil are commonly used as dosing vehicles in toxicology studies. Since these vegetable oils contain bioactive compounds, it is important for toxicology studies to characterize the toxicities of the dosing vehicles themselves. It has been recently proposed that the width of the genital tubercle (GT), the dorsal-ventral length (D-V length) of the GT, and urethral tube closure in mouse fetuses can be used as novel markers for monitoring sexual development in mice. However, how these parameters are influenced by the dosing vehicles themselves remains unclear. Therefore, we evaluated the effects of corn oil, sesame oil, and 10% ethanol in corn oil on GT width, D-V length, and GT morphology in ICR mice. Our results showed that all three vehicles influenced GT width and D-V length, but not GT morphology, suggesting that the effects of dosing vehicles themselves might need to be considered when GT width or D-V length is used as a parameter to evaluate the effects of chemicals on GT development.


Subject(s)
Ethanol/adverse effects , Fetal Development/drug effects , Maternal-Fetal Exchange , Pharmaceutical Vehicles/adverse effects , Plant Oils/adverse effects , Sexual Development/drug effects , Animals , Corn Oil/administration & dosage , Corn Oil/adverse effects , Ethanol/administration & dosage , Female , Fetal Weight/drug effects , Injections, Subcutaneous , Male , Mice, Inbred ICR , Pharmaceutical Vehicles/administration & dosage , Placentation/drug effects , Plant Oils/administration & dosage , Pregnancy , Random Allocation , Reproducibility of Results , Sesame Oil/administration & dosage , Sesame Oil/adverse effects , Sex Characteristics , Sex Determination Processes/drug effects , Toxicity Tests/methods , Urogenital Abnormalities/chemically induced , Urogenital Abnormalities/embryology , Urogenital Abnormalities/pathology
11.
J Toxicol Sci ; 43(1): 19-24, 2018.
Article in English | MEDLINE | ID: mdl-29415948

ABSTRACT

Cadmium (Cd) is an environmental pollutant present in contaminated water, food and soil. Cd adversely affects fetal development. We exposed pregnant mice to daily oral doses of 5 and 10 mg/kg Cd and examined fetal growth. It was demonstrated that the exposure to Cd (10 mg/kg) during gestation caused fetal growth retardation (FGR). Investigation of the ubiquitin-proteasome system in fetal livers of mice exposed to gestational Cd revealed increased polyubiquitinated protein accumulation, contrasting with decreased levels of monoubiquitin protein. Moreover, the expression level of Ubc (encoding polyubiquitin C protein) was significantly decreased in 5 and 10 mg/kg Cd-treated groups in comparison with the control group. Therefore, we propose that decrease of monoubiquitin level and accumulation of polyubiquitinated protein in the fetal liver may be important factors in Cd-induced FGR.


Subject(s)
Cadmium Compounds/metabolism , Cadmium Compounds/toxicity , Environmental Pollutants/toxicity , Fetal Growth Retardation/chemically induced , Liver/drug effects , Liver/metabolism , Maternal Exposure/adverse effects , Ubiquitin C/metabolism , Animals , Female , Gestational Age , Liver/embryology , Male , Mice, Inbred C57BL , Pregnancy , Proteasome Endopeptidase Complex/metabolism , Ubiquitin/metabolism
12.
Sci Rep ; 7: 45931, 2017 04 12.
Article in English | MEDLINE | ID: mdl-28401920

ABSTRACT

Fibrates, which are widely used lipidaemic-modulating drugs, are emerging environmental pollutants. However, fibrate concentrations in the environment have not been thoroughly surveyed. Here, we determined concentrations of the most commonly used fibrates and their metabolites in source water and drinking water samples from ten drinking water treatment plants in Shanghai and Zhejiang, China, using solid-phase extraction and liquid chromatography-tandem mass spectrometry. All the target compounds were detected in at least some of the source water samples, at concentrations ranging from 0.04 ng/L (fenofibrate) to 1.53 ng/L (gemfibrozil). All the compounds except fenofibrate were also detected in at least some of the drinking water samples, at recoveries ranging from 35.5% to 91.7%, suggesting that these compounds are poorly removed by typical drinking water treatment processes. In a peroxisome proliferator-activated receptor α agonistic activity assay, the target compounds showed no significant activity at nanogram per litre concentrations; therefore, our results suggest that the fibrate concentrations in drinking water in Shanghai and Zhejiang, China do not significantly affect human health. However, because of the increasing westernization of the Chinese diet, fibrate use may increase, and thus monitoring fibrate concentrations in aquatic environments and drinking water in China will become increasingly important.


Subject(s)
Drinking Water/analysis , Fenofibrate/analysis , Gemfibrozil/analysis , Water Pollutants, Chemical/analysis , China , Chromatography, Liquid , Drinking Water/chemistry , Environmental Monitoring/methods , Fenofibrate/isolation & purification , Gemfibrozil/isolation & purification , Humans , Solid Phase Extraction , Tandem Mass Spectrometry , Water Pollutants, Chemical/isolation & purification , Water Purification/methods
13.
Environ Sci Technol ; 51(7): 4061-4068, 2017 04 04.
Article in English | MEDLINE | ID: mdl-28282128

ABSTRACT

2-Ethylhexyl diphenyl phosphate (EHDPP), an organophosphate flame retardant (OPFR), is frequently detected in human blood. In this study, the sensitive dual-luciferase reporter gene assay and molecular docking were used to investigate the activation of EHDPP to human peroxisome proliferator-activated receptor gamma (PPARG). Results show that EHDPP exhibited stronger PPARG activation (EC20: 2.04 µM) than triphenyl phosphate (TPhP) (EC20: 2.78 µM). EHDPP upregulated the gene expression of 3ß-hydroxysteroid dehydrogenase type 1 (3ß-HSD1) in human placental choriocarcinoma cells in a dose-dependent manner, and the lowest observable effective concentration was 10 µM, lower than that of TPhP (20 µM). EHDPP significantly altered progesterone secretion at a lower concentration (10 µM) than that of TPhP (20 µM), and both EHDPP and TPhP significantly promoted human chorionic gonadotropin (hCG) production at 20 µM. Furthermore, inactivation of PPARG by either a pharmacological inhibitor (GW9662) or small interfering RNA (siRNA) abolished the change in progesterone secretion and gene expression in the cells exposed to EHDPP, suggesting that the PPARG signaling pathway plays a role in the upregulation of progesterone by the two OPFRs. This is the first report to show that OPFRs can alter the biosynthesis of progesterone in the placenta, which could affect female reproduction and fetal development.


Subject(s)
Choriocarcinoma/metabolism , Organophosphates/metabolism , PPAR gamma/metabolism , Progesterone/biosynthesis , Uterine Neoplasms/metabolism , Female , Humans , Molecular Docking Simulation , Pregnancy
14.
Biol Pharm Bull ; 39(10): 1596-1603, 2016.
Article in English | MEDLINE | ID: mdl-27725436

ABSTRACT

We investigated the ability of group 15 compounds with a triphenyl substituent to bind to and activate human retinoic X receptor (RXR) and peroxisome proliferator-activated receptor (PPAR) γ and their ability to activate the receptor. Triphenylphosphine oxide (TPPO) transcriptionally activated both RXR and PPARγ. Triphenylbismuth (TPBi) transcriptionally activated PPARγ but not RXR. However, TPBi significantly inhibited RXR transcriptional activity induced by 9-cis retinoic acid (9cRA) and PPARγ transcriptional activity induced by rosiglitazone (Rosi). Triphenylarsine (TPAs) also significantly inhibited the 9cRA- and Rosi-induced transcriptional activity of both receptors, whereas TPAs alone had no effect on the transcriptional activity of RXR and PPARγ. Consistent with these results, TPAs and TPBi blocked the binding of [3H]9cRA to RXR and of [3H]Rosi to PPARγ in a competitive manner. However, contrary to the results of the reporter gene assay, TPPO did not compete with [3H]9cRA and [3H]Rosi for binding to RXR and PPARγ, respectively. Our findings indicate that 1) TPPO is a transcriptional activator-but not a ligand-of RXR and PPARγ; 2) TPBi is an antagonist of RXR and a partial agonist of PPARγ; and 3) TPAs is a dual antagonist of RXR and PPARγ. These results suggest that TPPO, TPAs, and TPBi are potential endocrine disrupters of the PPARγ-RXR signaling pathway.


Subject(s)
Arsenicals/pharmacology , Organometallic Compounds/pharmacology , Organophosphorus Compounds/pharmacology , PPAR gamma/metabolism , Retinoid X Receptors/metabolism , Terphenyl Compounds/pharmacology , Alitretinoin , Cell Line, Tumor , DNA/metabolism , Genes, Reporter , Humans , Ligands , Luciferases, Renilla/genetics , PPAR gamma/agonists , PPAR gamma/genetics , Retinoid X Receptors/agonists , Retinoid X Receptors/genetics , Rosiglitazone , Thiazolidinediones/pharmacology , Transcription, Genetic/drug effects , Tretinoin/pharmacology
15.
Yakugaku Zasshi ; 136(6): 787-90, 2016.
Article in Japanese | MEDLINE | ID: mdl-27252054

ABSTRACT

The major duty of a school pharmacist is to serve as an expert in analysis. School pharmacists must perform regular and thorough assessments based on school environmental health standards. The objectives of the "environmental" component of the pharmacy education model core curriculum include performing analyses corresponding to the regularly checked items of the school environmental health standards. Students of the School of Pharmacy should cultivate their expertise in environmental analysis and environmental health, through practices such as sample collection, analysis operation, and evaluation of test results. As analysis experts, school pharmacists must know the principles and characteristics of analytical methods. The "Methods of Analysis in Health Science" published by the Pharmaceutical Society of Japan, provides comprehensive information on regular items to be cheked in the school environmental health standards, and school pharmacists should use this as a guide in their activities.


Subject(s)
Environmental Health/methods , Pharmacists , Professional Role , School Health Services , Curriculum , Education, Pharmacy , Environmental Health/standards , Humans
16.
Genesis ; 54(7): 389-97, 2016 07.
Article in English | MEDLINE | ID: mdl-27124574

ABSTRACT

Spermatogenesis is a complex and highly regulated process by which spermatogonial stem cells differentiate into spermatozoa. To better understand the molecular mechanisms of the process, the Cre/loxP system has been widely utilized for conditional gene knockout in mice. In this study, we generated a transgenic mouse line that expresses Cre recombinase under the control of the 2.5 kbp of the Prolactin family 3, subfamily b, member 1 (Prl3b1) gene promoter (Prl3b1-cre). Prl3b1 was initially reported to code for placental lactogen 2 (PL-2) protein in placenta along with increased expression toward the end of pregnancy. PL-2 was found to be expressed in germ cells in the testis, especially in spermatocytes. To analyze the specificity and efficiency of Cre recombinase activity in Prl3b1-cre mice, the mice were mated with reporter R26GRR mice, which express GFP ubiquitously before and tdsRed exclusively after Cre recombination. The systemic examination of Prl3b1-cre;R26GRR mice revealed that tdsRed-positive cells were detected only in the testis and epididymis. Fluorescence imaging of Prl3b1-cre;R26GRR testes suggested that Cre-mediated recombination took place in the germ cells with approximately 74% efficiency determined by in vitro fertilization. In conclusion, our results suggest that the Prl3b1-cre mice line provides a unique resource to understand testicular germ-cell development. genesis 54:389-397, 2016. © 2016 Wiley Periodicals, Inc.


Subject(s)
Cell Differentiation/genetics , Immediate-Early Proteins/biosynthesis , Protein Tyrosine Phosphatases/biosynthesis , Spermatogenesis/genetics , Spermatozoa/metabolism , Animals , Gene Expression Regulation, Developmental , Gene Knockout Techniques , Germ Cells/growth & development , Germ Cells/metabolism , Immediate-Early Proteins/genetics , Male , Mice , Placental Lactogen/genetics , Protein Tyrosine Phosphatases/genetics , Spermatozoa/growth & development , Stem Cells/metabolism , Testis/growth & development , Testis/metabolism
17.
Biol Pharm Bull ; 39(4): 587-92, 2016.
Article in English | MEDLINE | ID: mdl-27040631

ABSTRACT

The steroid hormones synthesized by the male gonads play diverse roles in biological processes. Androgens, the primary hormones produced by the male gonads, are key regulators of fat homeostasis, hence androgen-deprivation therapies often induce obesity. However, the molecular mechanism by which male gonadal dysfunction leads to obesity remains unclear, because results from animal studies regarding fat accumulation in the context of gonadal defects do not reflect clinical findings. Here, we investigated the mechanism underlying the development of obesity in animals with male gonadal dysfunction by analyzing the long-term physiological changes in adult male mice with surgical castration. Nine weeks after surgery, white adipose tissue (WAT) mass was higher in the castrated (Cas) mice than in sham-operated (Sham) mice. In addition, castration induced hyperlipidemia and hyperglycemia. However, genes involved in lipid metabolism, including hormone-sensitive lipase, were unchanged in the adipose tissue of the Cas mice, despite the increase in WAT. In contrast, a hepatic gluconeogenesis gene, glucose-6-phosphatase, was significantly upregulated in the Cas mice than in Sham mice. Our findings suggest that long-term hypogonadism in mice mimics the effects in humans, and a potential molecular basis for the induction of obesity in this model is impairment of hepatic gluconeogenesis.


Subject(s)
Gluconeogenesis , Hypogonadism/complications , Obesity/etiology , Adipose Tissue, White/pathology , Animals , Blood Glucose/analysis , Body Weight , Eating , Fatty Acids, Nonesterified/blood , Hyperglycemia/blood , Hyperglycemia/etiology , Hyperlipidemias/blood , Hyperlipidemias/etiology , Hypogonadism/blood , Liver/metabolism , Liver/pathology , Male , Mice, Inbred C57BL , Obesity/blood , Orchiectomy , Organ Size , Triglycerides/blood
18.
J Steroid Biochem Mol Biol ; 155(Pt B): 190-8, 2016 Jan.
Article in English | MEDLINE | ID: mdl-25465476

ABSTRACT

Organotin compounds, such as tributyltin (TBT) and triphenyltin (TPT), are typical environmental contaminants and suspected endocrine-disrupting chemicals because they cause masculinization in female mollusks. In addition, previous studies have suggested that the endocrine disruption by organotin compounds leads to activation of peroxisome proliferator-activated receptor (PPAR)γ and retinoid X receptor (RXR). However, whether organotin compounds cause crucial toxicities in human development and reproduction is unclear. We here investigated the structure-dependent effect of 12 tin compounds on mRNA transcription of 3ß-hydroxysteroid dehydrogenase type I (3ß-HSD I) and progesterone production in human choriocarcinoma Jar cells. TBT, TPT, dibutyltin, monophenyltin, tripropyltin, and tricyclohexyltin enhanced progesterone production in a dose-dependent fashion. Although tetraalkyltin compounds such as tetrabutyltin increased progesterone production, the concentrations necessary for activation were 30-100 times greater than those for trialkyltins. All tested active organotins increased 3ß-HSD I mRNA transcription. We further investigated the correlation between the agonistic activity of organotin compounds on PPARγ and their ability to promote progesterone production. Except for DBTCl2, the active organotins significantly induced the transactivation function of PPARγ. In addition, PPARγ knockdown significantly suppressed the induction of mRNA transcription of 3ß-HSD I by all active organotins except DBTCl2. These results suggest that some organotin compounds promote progesterone biosynthesis in vitro by inducing 3ß-HSD I mRNA transcription via the PPARγ signaling pathway. The placenta represents a potential target organ for these compounds, whose endocrine-disrupting effects might cause local changes in progesterone concentration in pregnant women.


Subject(s)
17-Hydroxysteroid Dehydrogenases/genetics , Endocrine Disruptors/pharmacology , Organotin Compounds/pharmacology , PPAR gamma/genetics , Progesterone/agonists , Trophoblasts/drug effects , 17-Hydroxysteroid Dehydrogenases/metabolism , Cell Line, Tumor , Female , Gene Expression Regulation , Humans , PPAR gamma/antagonists & inhibitors , PPAR gamma/metabolism , Pregnancy , Progesterone/biosynthesis , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA, Small Interfering/genetics , Signal Transduction , Structure-Activity Relationship , Transcription, Genetic , Trophoblasts/metabolism , Trophoblasts/pathology
19.
Metallomics ; 7(7): 1180-8, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25985376

ABSTRACT

Organotins, such as tributyltin (TBT) and triphenyltin (TPT), may disrupt endocrine activity in mammals arising from their ability to act as ligands for the retinoid X receptor (RXR) and the peroxisome proliferator-activated receptor γ (PPARγ). The structure of TBT is completely different from that of 9-cis retinoic acid (9cRA), an endogenous RXR ligand; and X-ray crystallographic studies have revealed that TBT and 9cRA have distinct binding interactions with human RXRα. Therefore, organotins and rexinoids likely activate RXR by different mechanisms. Here, we used human RXRα mutants to investigate which amino acid residues of the receptor are critical for transactivation induced by rexinoids and organotins. We found that 9cRA and a synthetic RXR agonist (LG100268) failed to activate R316A and L326A RXRα mutants. In contrast, all the tested organotins activated the R316A mutant, the L326A mutant, or both but failed to activate a C432A mutant. These results suggest that the importance of L326, which is located in the ß-strand, for rexinoid-induced transactivation of RXRα is comparable to that of R316; in contrast, C432 is critical for organotin-induced transactivation, whereas R316 and L326 are not required. We used a PPARγ/RXRα C432A heterodimer to determine whether TBT and TPT could activate the heterodimer by binding to PPARγ. We found that TBT and TPT activated the PPARγ/RXRα C432A heterodimer, which suggests that both compounds can activate the heterodimer through PPARγ. These findings indicate that the amino acid residues that are critical for organotin-induced transactivation of RXRα are distinct from those required for rexinoid-induced transactivation.


Subject(s)
Organotin Compounds/pharmacology , Retinoid X Receptor alpha/genetics , Transcriptional Activation/drug effects , Tretinoin/pharmacology , Trialkyltin Compounds/pharmacology , Alitretinoin , Cell Line, Tumor , Humans , Point Mutation , Retinoid X Receptor alpha/chemistry
20.
Article in English | MEDLINE | ID: mdl-25705434

ABSTRACT

A practical method for the elimination of PCBs from PCB-contaminated soil has been developed by the combination of Soxhlet extraction using a newly-developed modified Soxhlet extractor possessing an outlet valve on the extraction chamber with the chemical degradation. Various types of PCBs contaminated in soils could be completely extracted in refluxing hexane, and the subsequent hydrodechlorination could also be completed within 1 h in a hexane-MeOH (1 : 5) solution in the presence of Pd/C and Et3N under ordinary hydrogen pressure and temperature without the transfer of the extracted PCBs to other reaction container (a complete one-pot procedure). The present system is quite useful as a simple, safe, mild and reliable remediation method of PCB-contaminated soil.

SELECTION OF CITATIONS
SEARCH DETAIL